The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Voice, J.
Right arrow Articles by Goetzl, E. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Voice, J.
Right arrow Articles by Goetzl, E. J.
The Journal of Immunology, 2004, 172: 7289-7296.
Copyright © 2004 by The American Association of Immunologists

c-Maf and JunB Mediation of Th2 Differentiation Induced by the Type 2 G Protein-Coupled Receptor (VPAC2) for Vasoactive Intestinal Peptide1

Julia Voice*, Samantha Donnelly{dagger}, Glenn Dorsam*, Gregory Dolganov{dagger}, Sudhir Paul{ddagger} and Edward J. Goetzl2,*

* Departments of Medicine and Microbiology/Immunology, {dagger} Division of Pulmonary Medicine, Cardiovascular Research Institute, University of California Medical Center, San Francisco, CA 94143; and {ddagger} Departments of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston, TX 77030

Vasoactive intestinal peptide and its G protein-coupled receptors, VPAC1 and VPAC2, regulate critical aspects of innate and adaptive immunity. T cell VPAC2Rs mediate changes in cytokine generation, which potently increase the Th2/Th1 ratio and consequently shift the effector responses toward allergy and inflammation. To examine mechanisms of VPAC2 promotion of the Th2 phenotype, we analyzed controls of IL-4 transcription in CD4 T cells from T cell-targeted VPAC2 transgenic (Tg), VPAC2 knockout, and wild-type (WT) mice. c-maf and junB mRNA, protein, and activity were significantly up-regulated to a higher level in TCR-stimulated CD4 T cells from Tg mice compared with those from knockout and WT C57BL/6 mice. In contrast, GATA3, T-bet, and NFATc levels were identical in WT and Tg CD4 T cells. Vasoactive intestinal peptide binding to VPAC2 on CD4 T cells specifically induces an up-regulation of the Th2-type transcription factors c-Maf and JunB, which consequently enhances IL-4 and IL-5 production, leading to a Th2-type phenotype.




This article has been cited by other articles:


Home page
Ann Rheum DisHome page
E. Gonzalez-Rey, P. Anderson, and M. Delgado
Emerging roles of vasoactive intestinal peptide: a new approach for autoimmune therapy
Ann Rheum Dis, November 1, 2007; 66(suppl_3): iii70 - iii76.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
W. Wang, M.-C. Huang, and E. J. Goetzl
Type 1 Sphingosine 1-Phosphate G Protein-Coupled Receptor (S1P1) Mediation of Enhanced IL-4 Generation by CD4 T Cells from S1P1 Transgenic Mice
J. Immunol., April 15, 2007; 178(8): 4885 - 4890.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. M. Szema, S. A. Hamidi, S. Lyubsky, K. G. Dickman, S. Mathew, T. Abdel-Razek, J. J. Chen, J. A. Waschek, and S. I. Said
Mice lacking the VIP gene show airway hyperresponsiveness and airway inflammation, partially reversible by VIP
Am J Physiol Lung Cell Mol Physiol, November 1, 2006; 291(5): L880 - L886.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M.-C. Huang, A. L. Miller, W. Wang, Y. Kong, S. Paul, and E. J. Goetzl
Differential Signaling of T Cell Generation of IL-4 by Wild-Type and Short-Deletion Variant of Type 2 G Protein-Coupled Receptor for Vasoactive Intestinal Peptide (VPAC2).
J. Immunol., June 1, 2006; 176(11): 6640 - 6646.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
V. Sharma, M. Delgado, and D. Ganea
Granzyme B, a New Player in Activation-Induced Cell Death, Is Down-Regulated by Vasoactive Intestinal Peptide in Th2 but Not Th1 Effectors
J. Immunol., January 1, 2006; 176(1): 97 - 110.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.